EGFR and glioblastoma: As both secondary glioblastomas and TP53 mutations have been shown to have a better prognosis with a longer survival time as compared to primary glioblastoma and EGFR amplification, this could be one potential reason that blacks and Asians with glioblastoma may live longer than whites [2, 18].